首页> 美国卫生研究院文献>Chinese Medical Journal >Efficacy of Pegylated Interferon Monotherapy versus Sequential Therapy of Entecavir and Pegylated Interferon in Hepatitis B e Antigen-Positive Hepatitis B Patients: A Randomized Multicenter Phase IIIb Open-Label Study (POTENT Study)
【2h】

Efficacy of Pegylated Interferon Monotherapy versus Sequential Therapy of Entecavir and Pegylated Interferon in Hepatitis B e Antigen-Positive Hepatitis B Patients: A Randomized Multicenter Phase IIIb Open-Label Study (POTENT Study)

机译:聚乙二醇干扰素单药治疗与恩替卡韦和聚乙二醇干扰素序贯治疗对乙型肝炎e抗原阳性的乙型肝炎患者的疗效:一项随机多中心IIIb期开放标签研究(POTENT研究)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Until now, various types of combined therapy with nucleotide analogs and pegylated interferon (Peg-INF) in patients with hepatitis B patients have been tried. However, studies regarding the benefits of de novo combination, late-add on, and sequential treatment are very limited. The objective of the current study was to identify the efficacy of sequential treatment of Peg-INF after short-term antiviral treatment.
机译:背景:到目前为止,已经尝试了多种类型的核苷酸类似物与聚乙二醇化干扰素(Peg-INF)联合治疗乙型肝炎患者的疗法。但是,有关从头组合,延迟添加和序贯治疗的益处的研究非常有限。本研究的目的是确定短期抗病毒治疗后序贯治疗Peg-INF的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号